Repro Med Systems, Inc., doing business as KORU Medical Systems, designs, manufactures, and markets portable medical devices primarily for the ambulatory infusion market in the United States and internationally. The company is headquartered in Chester, New York.
| Revenue (TTM) | $41.13M |
| Gross Profit (TTM) | $25.60M |
| EBITDA | $-2.28M |
| Operating Margin | -5.02% |
| Return on Equity | -15.60% |
| Return on Assets | -6.71% |
| Revenue/Share (TTM) | $0.89 |
| Book Value | $0.37 |
| Price-to-Book | 11.72 |
| Price-to-Sales (TTM) | 4.78 |
| EV/Revenue | 4.729 |
| EV/EBITDA | -17.15 |
| Quarterly Earnings Growth (YoY) | -66.00% |
| Quarterly Revenue Growth (YoY) | 23.30% |
| Shares Outstanding | $46.37M |
| Float | $34.13M |
| % Insiders | 9.24% |
| % Institutions | 56.86% |